[Effects of 1-(7-indenyloxy)-3-isopropylaminopropan-2-ol hydrochloride (YB-2) on coronary circulation and and myocardial metabolism].
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000494:pharmacology*; D000605:Amino Alcohols / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D003326:Coronary Circulation / Q000187:drug effects*; D004285:Dogs; D004357:Drug Synergism; D004837:Epinephrine / Q000494:pharmacology; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D005947:Glucose / Q000378:metabolism; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D066298:In Vitro Techniques; D007192:Indenes / Q000494:pharmacology*; D007269:Injections, Intra-Arterial; D007545:Isoproterenol / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D009206:Myocardium / Q000378:metabolism*; D010101:Oxygen Consumption / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D005230:Fatty Acids, Nonesterified; D007192:Indenes; D005947:Glucose; D007545:Isoproterenol; D004837:Epinephrine